FDA Adverse Event Injury Summary report: N

GLOBAL ADVANTAGE HUM HD 52X18

MDR report key: 3851202 · Received June 5, 2014

Report

Report Number
1818910-2014-20275
Event Type
Injury
Date Received
June 5, 2014
Date of Event
May 9, 2014
Report Date
May 9, 2014
Manufacturer
DEPUY ORTHOPAEDICS, INC. 1818910
Product Code
KWT
PMA / PMN Number
PK984541
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS ONGOING. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. NO ADDITIONAL INFORMATION WAS OBTAINED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

THE PATIENT WAS REVISED BECAUSE THE STEM WAS LOOSE. OSTEOLYSIS WAS NOTED BUT THE PATIENT HAD A NATURAL GLENOID, NO POLY PRODUCTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
329946 GLOBAL ADVANTAGE HUM HD 52X18 SHOULDER HEAD/GLENOSPHERE KWT DEPUY ORTHOPAEDICS, INC. 1818910 VL4DR1

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention